This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) slid 4.47% to $325.84 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 2.14% to 14,255.48 and Dow Jones Industrial Average falling 0.94% to 34,002.92. This was the stock's second consecutive day of losses. Moderna Inc. closed $171.65 short of its 52-week high ($497.49), which the company achieved on August 10th.
The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc. (ABBV) fell 0.33% to $108.73, Amgen Inc. (AMGN) fell 1.16% to $211.44, and AstraZeneca PLC ADR (AZN.LN) rose 1.44% to $60.54. Trading volume (23.3 M) eclipsed its 50-day average volume of 18.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 4, 2021.
(END) Dow Jones Newswires
October 04, 2021 16:32 ET (20:32 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.